Literature DB >> 22956707

A randomized controlled trial of a tailored primary care program to reverse excessive alcohol consumption.

Mirrian Hilbink1, Gerlienke Voerman, Ivonne van Beurden, Brenda Penninx, Miranda Laurant.   

Abstract

OBJECTIVES: To assess the effects of a tailored, multifaceted intervention in primary care on the level of patients' alcohol consumption and to investigate which patient and organizational factors determine a reduction in alcohol consumption.
METHODS: This was a cluster randomized, controlled trial conducted among primary care practices in The Netherlands. Data from 6318 patients were available, of whom 712 patients from 70 practices were hazardous or harmful alcohol users. The improvement (intervention) program combined professional, organizational, and patient-directed activities. The emphasis was on educational training for general practitioners and support visits by a trained facilitator, tailored to the participants' needs and attitudes. The primary outcome was the proportion of patients with hazardous or harmful alcohol consumption, as measured with the Alcohol Use Disorders Identification Test, who reduced their levels of alcohol consumption to low-risk levels after 2 years.
RESULTS: Of the hazardous and harmful alcohol users, a substantial proportion (41.6%) reduced their alcohol consumption to a low-risk level. The trial revealed a significant difference in favor of the control group: 35.5% of the patients with hazardous and harmful alcohol consumption in general practitioners' practices in the intervention group and 47.0% of this patient group in general practitioners' practices in the control group reduced their alcohol consumption to a low-risk level (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.43-0.90). Older age (OR, 1.02; 95% CI, 1.01-1.03), female sex (OR, 2.00; 95% CI, 1.26-3.19), and attitudes toward alcohol use seemed to be the most important predictors for the reduction of alcohol use to a low-risk level. Patients who considered it important to reduce alcohol consumption and patients who believed that less alcohol complicates relaxation were less likely to reduce their alcohol use to a low-risk level (OR, 0.39; 95% CI, 0.19-0.80 and OR, 0.58; 95% CI, 0.37-0.90, respectively). Characteristics of the general practices, however, were not associated with reduced alcohol use.
CONCLUSIONS: Our results suggest that the intervention has been counterproductive because the proportion of patients reducing their levels of alcohol consumption to low-risk levels was lower in the intervention group compared with the control group. Furthermore, our study demonstrated that patients' attitudes toward alcohol use are an important determinant of the success of the program. Therefore, future research should focus on the effectiveness of methods to change patients' attitudes.

Entities:  

Mesh:

Year:  2012        PMID: 22956707     DOI: 10.3122/jabfm.2012.05.120070

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  17 in total

1.  Encouraging innovation, unintended consequences, and group-level research.

Authors:  Robert L Williams; Kurt Stange; William R Phillips; Louise S Acheson; Bijal Balasubramanian; Elizabeth A Bayliss; Robert L Ferrer; James M Gill
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

2.  Alcohol brief intervention in primary care: Blood pressure outcomes in hypertensive patients.

Authors:  Felicia W Chi; Constance M Weisner; Jennifer R Mertens; Thekla B Ross; Stacy A Sterling
Journal:  J Subst Abuse Treat       Date:  2017-03-22

3.  Cannabis and Young Users-A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care.

Authors:  Catherine Laporte; Hélène Vaillant-Roussel; Bruno Pereira; Olivier Blanc; Bénédicte Eschalier; Shérazade Kinouani; Georges Brousse; Pierre-Michel Llorca; Philippe Vorilhon
Journal:  Ann Fam Med       Date:  2017-03       Impact factor: 5.166

4.  Lost in translation: The perils of implementing alcohol brief intervention when there are gaps in evidence and its interpretation.

Authors:  Richard Saitz
Journal:  Addiction       Date:  2014-07       Impact factor: 6.526

5.  Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV.

Authors:  Emily C Williams; Gwen T Lapham; Jennifer F Bobb; Anna D Rubinsky; Sheryl L Catz; Susan M Shortreed; Kara M Bensley; Katharine A Bradley
Journal:  J Subst Abuse Treat       Date:  2017-04-13

6.  Testing the efficacy of motivational strategies, empathic reflections, and lifelike features in a computerized intervention for alcohol use: A factorial trial.

Authors:  Emily R Grekin; Jessica R Beatty; Lucy McGoron; Kari C Kugler; Jennifer B McClure; Damaris E Pop; Steven J Ondersma
Journal:  Psychol Addict Behav       Date:  2019-08-22

7.  Computer-Delivered Screening and Brief Intervention for Alcohol Use in Pregnancy: A Pilot Randomized Trial.

Authors:  Steven J Ondersma; Jessica R Beatty; Dace S Svikis; Ronald C Strickler; Golfo K Tzilos; Grace Chang; George W Divine; Andrew R Taylor; Robert J Sokol
Journal:  Alcohol Clin Exp Res       Date:  2015-05-22       Impact factor: 3.455

8.  An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration.

Authors:  Emily C Williams; Anna D Rubinsky; Laura J Chavez; Gwen T Lapham; Stacey E Rittmueller; Carol E Achtmeyer; Katharine A Bradley
Journal:  Addiction       Date:  2014-06-12       Impact factor: 6.526

9.  A randomised trial of a computer-delivered screening and brief intervention for postpartum alcohol use.

Authors:  Steven J Ondersma; Dace S Svikis; Leroy R Thacker; Jessica R Beatty; Nancy Lockhart
Journal:  Drug Alcohol Rev       Date:  2016-03-23

10.  A Randomized Controlled Trial of Brief Intervention by Interactive Voice Response.

Authors:  Gail L Rose; Gary J Badger; Joan M Skelly; Charles D MacLean; Tonya A Ferraro; John E Helzer
Journal:  Alcohol Alcohol       Date:  2017-05-01       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.